NCT00205062
Terminated
Phase 4
Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease
ConditionsInflammatory Bowel Diseases
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Inflammatory Bowel Diseases
- Sponsor
- University of Wisconsin, Madison
- Locations
- 1
- Primary Endpoint
- Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?
- Status
- Terminated
- Last Updated
- 10 years ago
Overview
Brief Summary
The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient with either Crohn's disease or ulcerative colitis whose disease is flaring
Exclusion Criteria
- •Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT
Outcomes
Primary Outcomes
Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?
Secondary Outcomes
- Does this technique provide additional information for practitioners on extent of disease?
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyCarcinoma of Unknown PrimaryHead and Neck CancerNCT00388024Wake Forest University Health Sciences19
Completed
Not Applicable
A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine ReactogenicityPositron-Emission TomographyImmunization ReactionNCT04515368Imperial College London54
Completed
Not Applicable
A Study to Assess Thymic Function Using PET/CT and MRICD34 Selected Peripheral Blood Stem Cell GraftNCT02909075Memorial Sloan Kettering Cancer Center3
Unknown
Not Applicable
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageProstate CancerNCT04116086Sheba Medical Center50
Recruiting
Early Phase 1
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular CarcinomaMalignant Neoplasm of LiverNCT06383520Wuhan Union Hospital, China100